Low Molecular Weight Dextran Infusions SIR,-Referring to the article by Dr. Peter Lane, "Low Molecular Weight Dextran Infusions in Systemic Sclerosis with Raynaud's Phenomenon: A report of Nine Cases" (12 December, p. 657), I should like to make the following comments.
Unfortunately, the exact values of the skin-temperatures before and after the low molecular dextran were not given, but only the differences. I am afraid therefore a very fundamental and very common mistake may have been made in the interpretation of these.
If the exposure to heat gives a maximum vasodilatation in the skin, it cannot be expected that increased blood flow will give a further rise in skin temperature. Furthermore, it is not certain when the patient's heat regulation is intact that plasma-expansion alone should increase peripheral blood flow. If the possible flow-improving effects of the low molecular dextran would cause an increased peripheral flow, this will not cause a further rise in skin temperature I have then seen a patient in whom the skin temperature of the thumb at the beginning was 10°C higher than that of the feet. After 10 days' treatment the skin temperature of the feet was 10 C higher than the temperature of the thumb before the last infusion was given. This shows a definite effect of improving the blood circulation in the lower extremities, where the vasomotor activity is still lost. The hands normally get warm before the feet.
This whole subject seems to me to be very controversial, and the results from different clinics are very difficult to compare. With our technique we have better results than those referred to in Dr. Lane's article. This may be due to the daily treatment over a longer period of time. Naturally, we have failures too, but I wanted to draw attention to the combined attempt of making the possible vasodilatation combined with the plasma-expansion and possible flow-improving effect of the low molecular dextran. It has proved itself very useful in the treatment of shock at times when conventional shock-therapy has not yet been effective.
I wish to compliment the author on his interest in this subject. There is much to be gained, and I agree with him that larger series than hi and mine are necessary before complete evaluation is possible. We probably need better diagnostic procedures as well. mg/100 ml (normal 0-4-0-6 mg/100 ml); haemoglobin 93 g/100 ml (64% of average normal); plasma proteins, albumin 2-7 g/100 ml and globulin 4-2 g/100 ml (albumin/ globulin ratio = 0-6/1). Chest x-ray showed marked enlargement in the transverse cardiac diameter. A diagnosis of depression, malnutrition, and thiamine deficiency was made.
Case 2 His lower limbs were ataxic and the calves wasted, and he had marked pitting ankle oedema. B;ood pyruvate 1.7 mg/100 ml; haemoglobin 9 8 g/100 ml (67% of average normal).
On the day after admission he had two grand mal attacks. Two E.E.G's showed no focal abnormality, and since he later admitted taking large quantities of barbiturates daily over several months these were regarded as barbiturate-withdrawal fits (seven days after admission his blood barbiturate level was 0 9 mg/100 ml). A diagnosis of depression, malnutrition with thiamine deficiency, and barbiturate addiction was made.
Both patients were given daily intravenous vitamin injections (Parentrovite) and oral iron. Within three weeks depression and oedema had cleared and they had gained weight. At discharge they were well physically and mentally.
Vitamin deficiency diseases occur sporadically in the British Isles and are then usually conditiond by other factors-gastrointestinal and psychiatric disorders, alcoholism, food-faddism, and social isolation
